A Phase II Study of Sagopilone (ZK 219477; ZK-EPO) in Patients With Breast Cancer and Brain Metastases

Treatments for women with recurrent brain metastases from breast cancer are limited. In this phase II study, we administered sagopilone to patients with breast cancer and brain metastases. We observed modest activity with a central nervous system objective response rate of 13.3%; however, median PFS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Freedman, Rachel A., Bullitt, Elizabeth, Sun, Lixian, Gelman, Rebecca, Harris, Gordon, Ligibel, Jennifer A., Krop, Ian E., Partridge, Ann H., Eisenberg, Emily, Winer, Eric P., Lin, Nancy U.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3773692/
https://ncbi.nlm.nih.gov/pubmed/21697017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2011.03.024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados